Mccormick Frank
Director at BBIO
- Sold, on record
- $33.9M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Oct 29, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BBIOBridgeBio Pharma, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BBIOPlan not statedDec 30 2019
Sold 100,000 shares at $37.55 ($3.8M)
Mccormick Frank, Chairman of Oncology
Sold 7.3% of holdings ($51.1M position)1.3M shares leftFirst sale on recordFiling
- 2 Form 4 sale BBIOPlan not statedNov 13 +319 days
Sold 100,000 shares at $42.76 ($4.3M)
Mccormick Frank, Chairman of Oncology
Sold 7.7% of holdings ($55.6M position)1.2M shares leftFiling
- 3 Form 4 sale BBIORoutineDec 26 +1138 days
Sold 100,000 shares at $42.06 ($4.2M)
Mccormick Frank, Director
10b5-1 planSold 13.7% of holdings ($30.6M position)627,689 shares leftFirst sale on recordFiling
- 4 Form 4 sale BBIORoutineJun 24 +546 days
Sold 100,000 shares at $44.23 ($4.4M)
Mccormick Frank, Director
10b5-1 planSold 10.2% of holdings ($43.3M position)879,979 shares leftFiling
- 5 Form 4 sale BBIOUnusualSep 5 +73 days
Sold 74,000 shares at $53.16 ($3.9M)
Mccormick Frank, Director
No 10b5-1 planSold 47.1% of holdings ($8.4M position)83,275 shares leftFiling
- 6 Form 4 sale BBIORoutineOct 27 +52 days
Sold 1,641 shares at $65.00 ($107k)
Mccormick Frank, Director
10b5-1 planSold 0.2% of holdings ($57.2M position)878,338 shares left0x usual sizeFiling
- 7 Form 4 sale BBIORoutineOct 29 +2 days
Sold 198,359 shares at $66.58 ($13.2M)
Mccormick Frank, Director
10b5-1 planSold 22.6% of holdings ($58.5M position)679,979 shares left2.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Oct 29, 2025 | BBIO | Director | Form 4 sale | 198,359 | $13.2M | 22.6% | Routine | SEC |
| Oct 27, 2025 | BBIO | Director | Form 4 sale | 1,641 | $107k | 0.2% | Routine | SEC |
| Sep 5, 2025 | BBIO | Director | Form 4 sale | 74,000 | $3.9M | 47.1% | Unusual | SEC |
| Jun 24, 2025 | BBIO | Director | Form 4 sale | 100,000 | $4.4M | 10.2% | Routine | SEC |
| Dec 26, 2023 | BBIO | Director | Form 4 sale | 100,000 | $4.2M | 13.7% | Routine | SEC |
| Nov 13, 2020 | BBIO | Chairman of Oncology | Form 4 sale | 100,000 | $4.3M | 7.7% | Plan not stated | SEC |
| Dec 30, 2019 | BBIO | Chairman of Oncology | Form 4 sale | 100,000 | $3.8M | 7.3% | Plan not stated | SEC |